Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Randomized Double-blind Study of TAS-102 in Chemotherapy-Refractory Advanced Colorectal Cancer
jRCT2080220849Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colorectal cancer (CRC) comparing TAS-102 with Placebo (2 arms).
02
Drugs
trifluridine + tipiracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT2080220849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220849.